Cancer Forums and News by PhD's


News | Forums Register

Go Back   Cancer Forums and News by PhD's > Cancer Forums and News

Cancer News

Breast
Colon
Kidney
Leukemia
Liver
Lung
Melanoma
Mesothelioma
Myeloma
Neck
Pancreatic
Prostate


Cancer Review

Breast
Colon
Kidney
Leukemia
Liver
Lung
Melanoma
Mesothelioma
Myeloma
Pancreatic
Prostate


Recent Forum Topics

 
Prostate
PSA test for men could get a second life for breast cancer in women
By Dross at 2011-07-16 03:10
 

 

The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ACS journal Analytical Chemistry.

read more | 19517 reads

Finger length points to prostate cancer risk
By Dross at 2010-12-01 23:39
 

 

Men who have long index fingers are at lower risk of prostate cancer, a new study published today in the British Journal of Cancer has found.

read more | 1 comment | 2129 reads

New prostate cancer imaging shows real-time tumor metabolism
By Dross at 2010-11-29 21:24
 


A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor's metabolism.

read more | 1675 reads

Study: Prostate cancer treatment linked to higher rate of colon cancer | University of Michigan Health System
By Dross at 2010-11-16 03:48
 

NN ARBOR, Mich. — Men treated with hormone-based therapy for prostate cancer faced a 30 percent to 40 percent higher risk of colorectal cancer, compared to patients who did not receive this treatment, according to a new study.

read more | 2214 reads

Surgery Offers Long-Term Survival for Early-Stage Prostate Cancer Patients
By Dross at 2010-09-30 03:42
 

In the largest, most modern, single-institution study of its kind, Mayo Clinic urologists mined a long-term data registry for survival rates of patients who underwent radical prostatectomy for localized prostate cancer. The findings are being presented at the North Central Section of the American Urological Association's 84th Annual Meeting in Chicago.

A radical prostatectomy is an operation to remove the prostate gland and some of the tissue around it.

read more | 1768 reads

Blood test accurately predicts death from prostate cancer up to 25 years in advance
By Dross at 2010-09-15 21:45
 

NEW YORK, September 14, 2010 – A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden. The findings, published today online in the British Medical Journal, could have important implications for determining which men should be screened after the age of 60 and which may not benefit substantially from continued prostate cancer screening.

read more | 2099 reads

Anti-cancer effects of broccoli ingredient explained
By Dross at 2010-07-14 03:45
 

Light has been cast on the interaction between broccoli consumption and reduced prostate cancer risk. Researchers writing in BioMed Central's open access journal Molecular Cancer have found that sulforaphane, a chemical found in broccoli, interacts with cells lacking a gene called PTEN to reduce the chances of prostate cancer developing.

read more | 2053 reads

High-risk prostate cancer associated with significantly lower bone mineral content loss
By Dross at 2010-07-14 03:32
 

Men with prostate cancer lose significantly less bone mineral content (BMC) as they age than men who are free of the disease, according to research in the July issue of BJUI. The findings are important because loss of BMC can play a key role in the development of fragile bones, fractures and osteoporosis.

read more | 1 comment | 1660 reads

Experts issue call to reconsider screening for breast cancer and prostate cancer
By Dross at 2009-10-21 18:13
 

Twenty years of screening for breast and prostate cancer – the most diagnosed cancer for women and men – have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."

read more | 1 comment | 2358 reads

Minimally invasive radical prostatectomy shows advantages, but also certain complications
By Dross at 2009-10-15 10:42
 

New research indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy, which have increased significantly in recent years, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

read more | 1643 reads

Gene activity reveals dynamic stroma microenvironment in prostate cancer
By Dross at 2009-06-09 21:26
 

HOUSTON -- (June 9, 2009) – As stroma – the supportive framework of the prostate gland – react to prostate cancer, changes in the expression of genes occur that induce the formation of new structures such as blood vessels, nerves and parts of nerves, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Clinical Cancer Research.

read more | 1871 reads

Diet May Reduce Risk of Prostate Cancer
By Dross at 2009-06-04 09:45
 

A new review published in the Journal of Human Nutrition and Dietetics assessed whether certain modifications in diet have a beneficial effect on the prevention of prostate cancer. Results suggest that a diet low in fat and red meat and high in fruits and vegetables is beneficial in preventing and treating prostate cancer.

 

Robert W.-L. Ma and K. Chapman conducted an evidence-based review of dietary recommendations in the prevention of prostate cancer as well as in the management of patients with prostate cancer.

 

read more | 1774 reads

Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known
By Dross at 2008-10-31 03:30
 

DURHAM, N.C. -- Popular cholesterol-busting drugs -- statins -- appear to lower men's PSA values along with their cholesterol levels, according to researchers in the Duke Prostate Center and the Durham Veterans Affairs Medical Center. But whether the drugs prevent prostate cancer growth or just mask it is not known yet.

"Previous studies had shown that men taking statins were less likely to develop advanced forms of prostate cancer but no one had looked at the relationship between the drugs and prostate-specific antigen, or PSA, a biomarker that is correlated with cancer growth and is the most common prostate cancer screening tool," said Stephen Freedland, M.D., a urologist at Duke and senior investigator on the study. "Our study represents a move to understand if and how statins influence prostate biology and whether they are really reducing cancer risk, or simply making PSA a less effective screening tool."

read more | 2130 reads

Cancer vaccine shows promise in patients with bowel, kidney and prostate cancer
By Dross at 2008-10-24 22:58
 

Geneva, Switzerland: Analysis of data from several phase I and II clinical trials of a new cancer vaccine has shown it is capable of eliciting an immune response in most patients with bowel, kidney and prostate cancer, and that it may provide clinical benefit.

In a news briefing at the 20th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Geneva yesterday (Thursday 23 October), Dr Richard Harrop, vice-president of clinical immunology at Oxford BioMedica, a UK-based biotechnology company – said: "Our exploratory analyses of data from nine different trials of TroVax® demonstrate significant associations between immune responses and overall survival in patients with colorectal cancer, renal cancer and prostate cancer.

read more | 2440 reads

Common painkillers lower levels of prostate cancer biomarker
By Dross at 2008-09-09 20:23
 

Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer.

But the authors of the study, which appears online Sept. 8 in the journal Cancer, caution that men shouldn't take the painkillers in an effort to prevent prostate cancer just yet.

"We showed that men who regularly took certain medications like aspirin and other non-steroidal anti-inflammatory drugs, or NSAIDS, had a lower serum PSA level," said first author Eric A. Singer, M.D., M.A., a urology resident at the University of Rochester Medical Center. "But there's not enough data to say that men who took the medications were less likely to get prostate cancer. This was a limited study, and we do not know how many of those men actually got prostate cancer."

read more | 3 comments | 1774 reads

Syndicate content
 
Search

sponsored links




Donate


Newsletter



Subscribe to our newsletter to receive info on our site or upcoming clinical trials
Email

Confirm your email address

HTML format
State

Please select the newsletters you want to sign up to:

  • Cancerfocus
    Receive updates from Cancerfocus.
  • Breast
  • Colon
  • Kidney
  • Leukemia
  • Liver
  • Lung
  • Melanoma
  • Mesothelioma
  • Myeloma
  • Neck
  • Pancreatic
  • Prostate




Syndicate
Syndicate content


All times are GMT -5. The time now is 05:04 PM.